MENU
+Compare
CRBU
Stock ticker: NASDAQ
AS OF
Jul 3 closing price
Price
$1.37
Change
-$0.00 (-0.00%)
Capitalization
127.42M

CRBU Caribou Biosciences Forecast, Technical & Fundamental Analysis

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies... Show more

CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CRBU with price predictions
Jul 03, 2025

CRBU's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Indicator for CRBU moved out of overbought territory on June 26, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 instances where the indicator moved out of the overbought zone. In of the 15 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 33 cases where CRBU's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CRBU turned negative on June 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 33 similar instances when the indicator turned negative. In of the 33 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRBU declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CRBU broke above its upper Bollinger Band on June 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRBU advanced for three days, in of 196 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 91 cases where CRBU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.587) is normal, around the industry mean (16.666). P/E Ratio (0.000) is within average values for comparable stocks, (58.763). CRBU's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.315). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (12.594) is also within normal values, averaging (269.614).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRBU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRBU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CRBU is expected to report earnings to fall 7.98% to -39 cents per share on August 12

Caribou Biosciences CRBU Stock Earnings Reports
Q2'25
Est.
$-0.40
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.04
The last earnings report on May 08 showed earnings per share of -43 cents, beating the estimate of -44 cents. With 746.49K shares outstanding, the current market capitalization sits at 127.42M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2929 7th Street
Phone
+1 510 982-6030
Employees
158
Web
https://www.cariboubio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PGPKY5.99N/A
N/A
PGE Polska Energetyczna SA
EDNMF30.45N/A
N/A
Edenred Malakoff
NTEI0.06N/A
N/A
Nova Tech Enterprises, Inc.
PTCHF1.65N/A
N/A
PureTech Health PLC
PWBK11.00N/A
N/A
Pacific West Bancorp

CRBU and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
N/A
CRSP - CRBU
62%
Loosely correlated
+0.97%
FATE - CRBU
56%
Loosely correlated
N/A
CCCC - CRBU
54%
Loosely correlated
-2.63%
BEAM - CRBU
54%
Loosely correlated
+0.65%
PRME - CRBU
53%
Loosely correlated
+1.30%
More